Akari Therapeutics (AKTX) Other Non-Current Assets (2015 - 2026)

Akari Therapeutics has disclosed Other Non-Current Assets across 8 years of filings, most recently posting $60000.0 for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $60000.0, down 97.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $60000.0 (down 97.73% YoY), and the FY2025 annual result was $60000.0, down 97.74% from the prior year.
• Other Non-Current Assets came in at $60000.0 for Q1 2026 at Akari Therapeutics, roughly flat from $60000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.2 million in Q2 2024 to a low of $60000.0 in Q2 2025.
• The 3-year median for Other Non-Current Assets is $1.3 million (2024), against an average of $1.5 million.
• Peak annual rise in Other Non-Current Assets reached 101.68% in 2025, while the deepest fall reached 98.56% in 2025.
• Akari Therapeutics' Other Non-Current Assets stood at $2.7 million in 2024, then sank by 97.74% to $60000.0 in 2025, then changed by 0.0% to $60000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $60000.0 (Q1 2026), $60000.0 (Q4 2025), and $60000.0 (Q3 2025), per Business Quant data.